Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chiron Response To FDA "483" Report For Fluvirin Plant Expected In Early August

Jul 28 2005

• By Andrew Shelton

Related Content

Chiron Refining GMP Remediation Plan Following FDA Warning Letter

Dec 10 2004

Chiron Will Not Supply Begrivac Flu Vaccine This Season

Jul 20 2005

Chiron To Meet With U.K. Regulatory Authorities On Fluvirin Suspension

Oct 05 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window